Enlarged Prostate (BPH) Clinical Trials

Find Enlarged Prostate (BPH) Clinical Trials Near You

GreenLight (532nm) LASER (XPS) Enucleation vs. Thulium LASER Enucleation of Prostate for Treatment of Benign Prostatic Hyperplasia

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In this study the investigators aim to test TGreenlight (532-nm) laser Photoselective Enucleation of the Prostate (Green LEP) using (XPS) 180W system ) vs Thulium Laser 200 W Enucleation of the Prostate (ThuLEP) in reduction of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) in a randomized controlled trial. Furthermore, all peri-operative parameters, urinary flow parameters, prostate size changes and complications associated with the procedures will be compared.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 40
Maximum Age: 80
Healthy Volunteers: f
View:

• Patients' age ≥ 40 years

• LUTS secondary to BOO due to BPH who failed medical treatment

• International prostate symptom scores (IPSS) \>15 and bother score (QOL) ≥ 3 (according to IPSS question 8)

• Peak urinary flow rate (Qmax) \<15 ml/sec with at least 125 ml voided volume or Patients with acute urine retention secondary to BPH who failed trial of voiding on medical treatment.

• ASA (American society of anaesthesiologists) score ≤3.

• TRUS prostate size \> /= 80 ml

Locations
Other Locations
Egypt
Urology and Nephrology Center
RECRUITING
Al Mansurah
Contact Information
Primary
Mahmoud Nabil Laymon, MD
dr_mahmoudlaymon@yahoo.com
00201002275698
Backup
Adel M Nabeeh, Professor
adel_nabeeh51@hotmail.com
0020100196665
Time Frame
Start Date: 2017-04-01
Estimated Completion Date: 2024-11-01
Participants
Target number of participants: 110
Treatments
Experimental: ThuLEP
Thulium laser enucleation of prostate
Experimental: Green LEP
Greenlight laser enucleation of prostate
Related Therapeutic Areas
Sponsors
Leads: Mansoura University

This content was sourced from clinicaltrials.gov